Amanote Research
Register
Sign In
Synergistic Effect of Histone Deacetylase Inhibitors FK228 and M-Carboxycinnamic Acid Bis-Hydroxamide With Proteasome Inhibitors PSI and PS-341 Against Gastrointestinal Adenocarcinoma Cells
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-03-0806
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 1, 2004
Authors
M. Adachi
Publisher
American Association for Cancer Research (AACR)
Related search
Inhibitors of Histone-Deacetylase
Journal of Applied Biomedicine
Genetics
Molecular Biology
Pharmacology
Biochemistry
Biological Sciences
Toxicology
Medicine
Agricultural
Neuroscience
Pharmaceutics
Pharmacogenomics and Histone Deacetylase Inhibitors
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Cancers
Cancer Research
Oncology
Histone Deacetylase Inhibitors Specifically Kill Nonproliferating Tumour Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
PS-341 and Histone Deacetylase Inhibitor Synergistically Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Nuclear Factor B Inhibitors Alleviate and the Proteasome Inhibitor PS-341 Exacerbates Radiation Toxicity in Zebrafish Embryos
Molecular Cancer Therapeutics
Cancer Research
Oncology
Histone Deacetylase Inhibitors From Burkholderia Thailandensis
Journal of Natural Products
Organic Chemistry
Molecular Medicine
Pharmacology
Complementary
Pharmaceutical Science
Analytical Chemistry
Alternative Medicine
Drug Discovery
A Potentiated Cooperation of Carbonic Anhydrase IX and Histone Deacetylase Inhibitors Against Cancer
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Enhancement of Ad5-Trail Cytotoxicity Against Renal Cell Carcinoma With Histone Deacetylase Inhibitors
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
